Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 60, Issue 6, Pages 985-993
Publisher
Wiley
Online
2012-12-19
DOI
10.1002/pbc.24433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized phase III trial of myeloablative autologous peripheral blood stem cell (PBSC) transplant (ASCT) for high-risk neuroblastoma (HR-NB) employing immunomagnetic purged (P) versus unpurged (UP) PBSC: A Children’s Oncology Group study
- (2017) S. G. Kreissman et al. JOURNAL OF CLINICAL ONCOLOGY
- Stratification of patients with neuroblastoma for targeted ALK inhibitor therapy.
- (2017) D. Weiser et al. JOURNAL OF CLINICAL ONCOLOGY
- Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial.
- (2017) R. L. Ladenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants
- (2012) Jed G. Nuchtern et al. ANNALS OF SURGERY
- Replication of Neuroblastoma SNP Association at the BARD1 Locus in African-Americans
- (2012) V. Latorre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity
- (2012) K. R. Bosse et al. CANCER RESEARCH
- Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Consortium Study
- (2012) Y. P. Mosse et al. CLINICAL CANCER RESEARCH
- Mechanisms of CHD5 Inactivation in Neuroblastomas
- (2012) H. Koyama et al. CLINICAL CANCER RESEARCH
- Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
- (2012) S. G. DuBois et al. CLINICAL CANCER RESEARCH
- Promising Therapeutic Targets in Neuroblastoma
- (2012) K. K. Matthay et al. CLINICAL CANCER RESEARCH
- Epigenetic Changes in Pediatric Solid Tumors: Promising New Targets
- (2012) E. R. Lawlor et al. CLINICAL CANCER RESEARCH
- Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial
- (2012) G.J. Veal et al. EUROPEAN JOURNAL OF CANCER
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641
- (2012) Douglas R. Strother et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
- (2012) Sharon J Diskin et al. NATURE GENETICS
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Erratum: Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma
- (2012) E L Carpenter et al. ONCOGENE
- Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma
- (2012) Y. H. Chanthery et al. Science Translational Medicine
- Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
- (2011) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells
- (2011) K.-O. Henrich et al. CANCER RESEARCH
- Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors
- (2011) Sheri L. Spunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study
- (2011) Julie R. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- CASZ1b, the Short Isoform of CASZ1 Gene, Coexpresses with CASZ1a during Neurogenesis and Suppresses Neuroblastoma Cell Growth
- (2011) Zhihui Liu et al. PLoS One
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma
- (2011) S. C. Bresler et al. Science Translational Medicine
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
- (2011) Lễ B. Nguyễn et al. PLoS Genetics
- Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy
- (2010) Christa E. Nath et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Global genomic and RNA profiles for novel risk stratification of neuroblastoma
- (2010) Miki Ohira et al. CANCER SCIENCE
- Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
- (2010) K. De Preter et al. CLINICAL CANCER RESEARCH
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
- (2010) Suzanne Shusterman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
- (2010) André Oberthuer et al. JOURNAL OF CLINICAL ONCOLOGY
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Racial and Ethnic Disparities in Risk and Survival in Children With Neuroblastoma: A Children's Oncology Group Study
- (2010) Tara O. Henderson et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma WithoutMYCNAmplification: Results of the Prospective INES 99.1
- (2010) Hervé Rubie et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study
- (2010) Rochelle Bagatell et al. JOURNAL OF CLINICAL ONCOLOGY
- Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program
- (2010) P. J. Houghton et al. MOLECULAR CANCER THERAPEUTICS
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
- (2010) David L. Baker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
- (2009) K Beiske et al. BRITISH JOURNAL OF CANCER
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
- (2009) R. J. Rounbehler et al. CANCER RESEARCH
- Busulfan in hematopoietic stem cell transplant setting
- (2009) Jeannine S McCune et al. Expert Opinion on Drug Metabolism & Toxicology
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Copy number variation at 1q21.1 associated with neuroblastoma
- (2009) Sharon J. Diskin et al. NATURE
- Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
- (2009) Mario Capasso et al. NATURE GENETICS
- Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro
- (2009) Holly J. Meany et al. PEDIATRIC BLOOD & CANCER
- Transcriptional adaptation of neuroblastoma cells to hypoxia
- (2008) Erik Fredlund et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
- (2008) B De Bernardi et al. BRITISH JOURNAL OF CANCER
- ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
- (2008) M. D. Hogarty et al. CANCER RESEARCH
- The prognostic impact of functional imaging with 123I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: Results of the German Neuroblastoma Trial NB97
- (2008) Matthias Schmidt et al. EUROPEAN JOURNAL OF CANCER
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- CHD5 , a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas
- (2008) Tomoyuki Fujita et al. JNCI-Journal of the National Cancer Institute
- Screening for neuroblastoma: a resurrected idea?
- (2008) John M Maris et al. LANCET
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
- (2008) Andrew DJ Pearson et al. LANCET ONCOLOGY
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma
- (2008) John M. Maris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
- (2008) Frank Westermann et al. GENOME BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started